Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Grupo Aeroportuario Centro Norte
OMAB
$5.19B
| $26.2M | 0.02% |
705,200
-193,500
| -22% | -$6.24M |
|
677
Aflac
AFL
$60.7B
| $26.2M | 0.02% |
+726,300
| New | +$26.2M |
|
678
Equinox Gold
EQX
$13.1B
| $26.1M | 0.02% |
2,325,000
+2,256,700
| +3,304% | +$20.2M |
|
679
Myers Industries
MYE
$1.25B
| $26M | 0.02% |
1,789,397
-30,700
| -2% | -$381K |
|
680
Quanex
NX
$981M
| $26M | 0.02% |
1,874,507
+34,509
| +2% | +$411K |
|
681
Suzano
SUZ
$9.84B
| $26M | 0.02% |
3,843,738
-26,391
| -0.7% | -$193K |
|
682
OR Royalties Inc
OR
$6.15B
| $26M | 0.02% |
2,598,300
-223,975
| -8% | -$2.07M |
|
|
RST
683
DELISTED
ROSETTA STONE INC
RST
| $26M | 0.02% |
1,540,823
-23,700
| -2% | -$398K |
|
684
10x Genomics
TXG
$7.58B
| $25.9M | 0.02% |
289,636
+279,100
| +2,649% | +$21.7M |
|
685
Camping World
CWH
$675M
| $25.8M | 0.02% |
+949,400
| New | +$15.3M |
|
|
CMA
686
DELISTED
Comerica
CMA
| $25.8M | 0.02% |
676,447
-25,219
| -4% | -$880K |
|
|
IAA
687
DELISTED
IAA, Inc. Common Stock
IAA
| $25.6M | 0.02% |
665,000
+571,000
| +607% | +$21.3M |
|
688
Nucor
NUE
$61.8B
| $25.6M | 0.02% |
619,180
+127,828
| +26% | +$5.17M |
|
|
TWNK
689
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $25.6M | 0.02% |
2,097,410
+1,150,500
| +122% | +$13.6M |
|
690
CNA Financial
CNA
$13.8B
| $25.5M | 0.02% |
794,400
-318,200
| -29% | -$9.8M |
|
|
TTM
691
DELISTED
Tata Motors Limited
TTM
| $25.5M | 0.02% |
3,884,908
-3,493,900
| -47% | -$20.1M |
|
|
NBL
692
DELISTED
Noble Energy, Inc.
NBL
| $25.4M | 0.02% |
2,839,528
-822,000
| -22% | -$7.35M |
|
693
State Street Financial Select Sector SPDR ETF
XLF
$59.5B
| $25.4M | 0.02% |
+1,098,700
| New | +$24.9M |
|
694
Robert Half
RHI
$4.48B
| $25.3M | 0.02% |
479,098
-17,700
| -4% | -$840K |
|
|
GMS
695
DELISTED
GMS Inc
GMS
| $25.3M | 0.02% |
1,028,602
-378,900
| -27% | -$7.22M |
|
|
NPTN
696
DELISTED
NEOPHOTONICS CORP
NPTN
| $25.3M | 0.02% |
2,845,784
+836,727
| +42% | +$7.21M |
|
697
Trane Technologies
TT
$105B
| $25.3M | 0.02% |
283,833
+48,336
| +21% | +$4.2M |
|
698
Hartford Financial Services
HIG
$37.8B
| $25.1M | 0.02% |
652,300
+615,500
| +1,673% | +$23.5M |
|
699
TIM SA
TIMB
$8.27B
| $25.1M | 0.02% |
1,940,334
-171,862
| -8% | -$2.14M |
|
700
CoreCivic
CXW
$3.13B
| $25M | 0.02% |
2,668,273
-1,730,200
| -39% | -$19.7M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.